LEAVO: A Multicentre Phase III Double-masked Randomised Controlled Non-Inferiority Trial comparing the clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema (MO) due to Central Retinal Vein Occlusion (CRVO)
LEAVO: A Multicentre Phase III Double-masked Randomised Controlled Non-Inferiority Trial comparing the clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema (MO) due to Central Retinal Vein Occlusion (CRVO)
1-19
Hykin, Philip
668bf80b-3b95-4522-9ff0-8303a692b77b
Sivaprasad, Sobha
7cd590d6-18f0-4ae1-8ace-4b35833c2f03
Prevost, A. Toby
5fd7066c-e170-46f6-8d3e-501532dc7810
Vasconcelos, Joana
a4f3ee8b-f054-4b73-b404-150b7336a8c7
Murphy, Caroline
6f95b133-c7a6-4852-96a8-52fe28fbc075
Kelly, Joanna
bc3e1b74-8080-478f-b7d5-87ae2819a325
Brazier, J.E.
55360b81-2c67-496d-9d38-62f852c405e9
Basarir, Hasan
82bfacaf-e40d-4abe-a409-fef786e22388
Harding, Simon
740d199f-f8fa-42d6-bb97-355f9a4e013f
Yang, Yit
eeb4171e-e1ce-422c-b02b-71d2dd962c9e
Chakravarthy, Usha
2c06cdaf-94c0-409a-8eff-2f624c120a5e
Lotery, Andrew
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
Hykin, Philip
668bf80b-3b95-4522-9ff0-8303a692b77b
Sivaprasad, Sobha
7cd590d6-18f0-4ae1-8ace-4b35833c2f03
Prevost, A. Toby
5fd7066c-e170-46f6-8d3e-501532dc7810
Vasconcelos, Joana
a4f3ee8b-f054-4b73-b404-150b7336a8c7
Murphy, Caroline
6f95b133-c7a6-4852-96a8-52fe28fbc075
Kelly, Joanna
bc3e1b74-8080-478f-b7d5-87ae2819a325
Brazier, J.E.
55360b81-2c67-496d-9d38-62f852c405e9
Basarir, Hasan
82bfacaf-e40d-4abe-a409-fef786e22388
Harding, Simon
740d199f-f8fa-42d6-bb97-355f9a4e013f
Yang, Yit
eeb4171e-e1ce-422c-b02b-71d2dd962c9e
Chakravarthy, Usha
2c06cdaf-94c0-409a-8eff-2f624c120a5e
Lotery, Andrew
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
Hykin, Philip, Sivaprasad, Sobha, Prevost, A. Toby, Vasconcelos, Joana, Murphy, Caroline, Kelly, Joanna, Brazier, J.E., Basarir, Hasan, Harding, Simon, Yang, Yit, Chakravarthy, Usha and Lotery, Andrew
(2016)
LEAVO: A Multicentre Phase III Double-masked Randomised Controlled Non-Inferiority Trial comparing the clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema (MO) due to Central Retinal Vein Occlusion (CRVO).
The Lancet, .
(In Press)
Text
Leavo.Protocol&Summary.rewrite.clean.doc
- Accepted Manuscript
Restricted to Registered users only
Request a copy
More information
Accepted/In Press date: 19 May 2016
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 399988
URI: http://eprints.soton.ac.uk/id/eprint/399988
ISSN: 0140-6736
PURE UUID: 7a6fad65-5af6-4de0-8d5f-86d92163b3b2
Catalogue record
Date deposited: 06 Sep 2016 14:42
Last modified: 22 Aug 2025 01:50
Export record
Contributors
Author:
Philip Hykin
Author:
Sobha Sivaprasad
Author:
A. Toby Prevost
Author:
Joana Vasconcelos
Author:
Caroline Murphy
Author:
Joanna Kelly
Author:
J.E. Brazier
Author:
Hasan Basarir
Author:
Simon Harding
Author:
Yit Yang
Author:
Usha Chakravarthy
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
